Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moderate neuromuscular blockade-Kuala Lumpur General Hospital refers to a specific clinical trial intervention arm (NCT02794714) conducted at Kuala Lumpur General Hospital. This regimen involves the administration of rocuronium, a non-depolarizing neuromuscular blocking agent, to achieve a moderate depth of muscle relaxation (defined by a Train of Four Count of 2) during laparoscopic gynecological surgeries. The protocol also includes the subsequent reversal of the blockade using sugammadex, a selective relaxant binding agent. The trial compares this moderate blockade level against deep neuromuscular blockade to evaluate surgical operating conditions and patient satisfaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on moderate neuromuscular blockade-Kuala Lumpur General Hospital.